The Cigna Group (NYSE:CI) Position Lifted by Altrius Capital Management Inc

Altrius Capital Management Inc raised its stake in shares of The Cigna Group (NYSE:CI) by 0.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,714 shares of the health services provider’s stock after acquiring an additional 53 shares during the quarter. Altrius Capital Management Inc’s holdings in The Cigna Group were worth $3,807,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in CI. Strategic Blueprint LLC raised its position in shares of The Cigna Group by 4.8% during the 3rd quarter. Strategic Blueprint LLC now owns 784 shares of the health services provider’s stock worth $224,000 after purchasing an additional 36 shares during the period. PDS Planning Inc grew its position in shares of The Cigna Group by 2.0% during the third quarter. PDS Planning Inc now owns 2,422 shares of the health services provider’s stock worth $693,000 after acquiring an additional 47 shares during the last quarter. Trinity Street Asset Management LLP grew its position in shares of The Cigna Group by 2.9% during the third quarter. Trinity Street Asset Management LLP now owns 61,347 shares of the health services provider’s stock worth $17,550,000 after acquiring an additional 1,751 shares during the last quarter. Commonwealth Equity Services LLC grew its position in shares of The Cigna Group by 5.9% during the third quarter. Commonwealth Equity Services LLC now owns 93,273 shares of the health services provider’s stock worth $26,683,000 after acquiring an additional 5,204 shares during the last quarter. Finally, Busey Trust CO grew its position in shares of The Cigna Group by 2.5% during the third quarter. Busey Trust CO now owns 53,046 shares of the health services provider’s stock worth $15,175,000 after acquiring an additional 1,286 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

The Cigna Group Stock Up 0.6 %

Shares of CI stock traded up $1.97 on Monday, hitting $356.44. The company’s stock had a trading volume of 1,073,617 shares, compared to its average volume of 1,564,747. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.67. The Cigna Group has a fifty-two week low of $240.50 and a fifty-two week high of $365.71. The firm’s fifty day moving average price is $349.88 and its 200-day moving average price is $318.15. The stock has a market capitalization of $104.21 billion, a price-to-earnings ratio of 20.38, a P/E/G ratio of 1.09 and a beta of 0.56.

The Cigna Group (NYSE:CI) last announced its earnings results on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, topping the consensus estimate of $6.54 by $0.25. The firm had revenue of $51.15 billion for the quarter, compared to the consensus estimate of $48.91 billion. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The business’s quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter last year, the firm posted $4.96 EPS. Research analysts anticipate that The Cigna Group will post 28.36 EPS for the current year.

The Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Investors of record on Tuesday, June 4th will be issued a $1.40 dividend. The ex-dividend date is Tuesday, June 4th. This represents a $5.60 annualized dividend and a yield of 1.57%. The Cigna Group’s dividend payout ratio (DPR) is presently 32.20%.

Insider Buying and Selling

In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of The Cigna Group stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares in the company, valued at approximately $694,668.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO David Cordani sold 38,065 shares of the business’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $335.22, for a total transaction of $12,760,149.30. Following the transaction, the chief executive officer now owns 329,321 shares in the company, valued at approximately $110,394,985.62. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business’s stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares in the company, valued at approximately $694,668.96. The disclosure for this sale can be found here. Insiders have sold 114,144 shares of company stock worth $39,296,330 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CI has been the subject of several recent research reports. Cantor Fitzgerald restated an “overweight” rating and set a $384.00 price target on shares of The Cigna Group in a research report on Wednesday, April 10th. Sanford C. Bernstein raised shares of The Cigna Group from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $330.00 to $372.00 in a report on Thursday, January 4th. StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a report on Thursday, March 14th. Morgan Stanley reissued an “overweight” rating and issued a $392.00 price target (up from $382.00) on shares of The Cigna Group in a report on Monday, March 4th. Finally, Deutsche Bank Aktiengesellschaft raised shares of The Cigna Group from a “hold” rating to a “buy” rating and upped their price objective for the company from $355.00 to $370.00 in a research note on Thursday, February 1st. Two investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, The Cigna Group currently has a consensus rating of “Buy” and an average target price of $362.14.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.